Neuralstem, Inc. News Headlines

CUR 
$1.73
*  
0.03
1.76%
Get CUR Alerts
*Delayed - data as of Jul. 28, 2015  -  Find a broker to begin trading CUR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CUR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



6 Stocks Under $10 Triggering Breakout Trades
7/23/2015 2:09:00 PM - TheStreet


The Race To Treat Spinal Cord Injury: A Comparative Analysis
7/16/2015 10:23:00 AM - Seeking Alpha




Next Week In Biotech: Baxter-Baxalta, BioLine RX Earnings
5/15/2015 9:00:00 AM - Seeking Alpha










An Expert's Opinion On Neuralstem's Phase 2 Results
3/20/2015 12:38:00 PM - Seeking Alpha






How Successful Was The Neuralstem Phase II Trial?
3/17/2015 8:23:00 AM - Seeking Alpha














NeoStem: The Levi Strauss Of Cell Therapy
2/12/2015 9:05:00 AM - Seeking Alpha






15 Biotech Names For 2015
1/5/2015 2:37:00 PM - Seeking Alpha


Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha


InVivo, Neuralstem Treat Spinal Cord Injury Patients
10/16/2014 1:53:00 PM - Seeking Alpha